Prescriptions For Life Science Investing
CROs run the gamut from international full-service organizations to niche specialty businesses. The emergence of the strategic partnership model, with some of the largest global pharma companies pairing with leading CROs in research and development (R&D), has stimulated the industry's growth.
A survey by Robert W. Baird analyst Eric Coldwell...
To view the full article, register now.